ライフサイエンスコーパス: diagnostic test

1 Prospective evaluation of a diagnostic test.

2 by real-time PCR and for malaria by a rapid diagnostic test.

3 ns for this technique's future as a clinical diagnostic test.

4 d greatly benefit from a rapid point-of-care diagnostic test.

5 IF assay is both sensitive and specific as a diagnostic test.

6 that fingerstick CRAG is a reliable bedside diagnostic test.

7 ideal candidate for development as a medical diagnostic test.

8 ty, isoform Amb a 1.01 should be included in diagnostic tests.

9 ly increase the sensitivity of malaria rapid diagnostic tests.

10 aimed at the development of new and specific diagnostic tests.

11 at might be relevant to the effectiveness of diagnostic tests.

12 tifungal strategies and utilization of newer diagnostic tests.

13 In total, 138 patients completed all diagnostic tests.

14 tate their translation into pathway-specific diagnostic tests.

15 ying new routes to improved therapeutics and diagnostic tests.

16 tries to achieve affordability for other new diagnostic tests.

17 are needed for retesting alongside improved diagnostic tests.

18 s, acknowledging the inherent limitations of diagnostic tests.

19 fected adults comparing favorably with other diagnostic tests.

20 and variable symptoms, and lack of reliable diagnostic tests.

21 emitter widely used in nuclear medicine for diagnostic tests.

22 pital admission, intensive care, surgery, or diagnostic tests.

23 ls for many molecular biology techniques and diagnostic tests.

24 tested with an extensive array of laboratory diagnostic tests.

25 spiration with ancillary tests were the main diagnostic tests.

26 ture of surveillance and poor sensitivity of diagnostic tests.

27 lysis of medical records, imaging and others diagnostic tests.

28 nd it improves the speed and availability of diagnostic testing.

29 isease Control and Prevention for Leishmania diagnostic testing.

30 nd show a need for global standardization of diagnostic testing.

31 als in making decisions about procedures and diagnostic testing.

32 d hygiene, environmental cleaning, and rapid diagnostic testing.

33 tain for purposes of transfusion therapy and diagnostic testing.

34 sures and may reduce the need for additional diagnostic testing.

35 nd show a need for global standardization of diagnostic testing.

36 iosensing applications including noninvasive diagnostic testing.

37 off-site, and have limited access to timely diagnostic testing.

38 Genetic diagnostic testing.

39 HBoV mRNA could be a useful target for diagnostic testing.

40 th a poor prognosis and those that can guide diagnostic testing.

41 also less likely to have a Giardia-specific diagnostic test (48% vs 58%; P < .001) and more likely t

42 After completion of all subsequent diagnostic tests, a total of 10,484 cases (0.88%) of bre

43 Purpose To assess the diagnostic test accuracy and sources of heterogeneity fo

44 There are few studies of diagnostic test accuracy to establish the sensitivity an

45 In studies of diagnostic test accuracy, authors sometimes report resul

46 ensive care or surgery admissions, number of diagnostic tests after infection, and hospital readmissi

47 The present findings will help improve diagnostic tests aimed at limiting risks of AGM invasion

48 CAD) and are often evaluated with the use of diagnostic testing, although there are limited data from

49 to assess the extent of variation in use of diagnostic testing among patients residing in the differ

50 High-resolution CT is a critical initial diagnostic test and acts as a tool to identify patients

51 In this work, we demonstrate a rapid diagnostic test and mobile enabled platform for simultan

52 ent and timely access to Xpert as an initial diagnostic test and to drug resistance screening.

53 vaccinated, sick dogs is a clinically useful diagnostic test and valuable prognostic indicator for ve

54 s include readily available Giardia-specific diagnostic testing and antiparasitic drugs.

55 te testing at the initial visit, much of the diagnostic testing and empirical treatment can be avoide

56 ntifies high-risk burn patients suitable for diagnostic testing and interventional HO prophylaxis tri

57 nd is associated with large expenditures for diagnostic testing and prescription and nonprescription

58 Adequacy of the tissue sample for diagnostic testing and rates of biopsy-related complicat

59 inical features of FI are useful for guiding diagnostic testing and therapy.

60 s, and highlight the need for more sensitive diagnostic tests and disease-specific treatments for thi

61 gaps include the feasibility of noninvasive diagnostic tests and imaging modalities as well as uncer

62 t combines response level data from multiple diagnostic tests and is able to 'hindcast' (infer the hi

63 Diagnostic tests and prescribed therapies increased by i

64 Diagnostic tests and prescribed therapies were also reco

65 We discuss the value of available diagnostic tests and review their role in management of

66 ng new anthelmintics, vaccines, and improved diagnostic tests and serve as a platform for future inve

67 y can be realistically translated into novel diagnostic tests and treatments.

68 challenges in developing rapid point-of-care diagnostic tests and vaccines to prevent disease.

69 y correlated with previously established DED diagnostic tests and whether it could serve as a novel o

70 uman body fluids, serum plays a key role for diagnostic tests and, increasingly, for metabolomics ana

71 care (e.g. coloured medication, colour-coded diagnostic tests), and modern life depend upon colour co

72 h improvement on a standardized mathematical diagnostic test, and this effect was strengthened by tRN

73 e long incubation period of MAP, inefficient diagnostic tests, and delayed clinical signs.

74 ase symptom patterns, performing appropriate diagnostic tests, and instituting early effective therap

75 pplementary questionnaire based on symptoms, diagnostic tests, and medications.

76 ifferences in number and sequence of visits, diagnostic tests, and prescriptions by age group (childr

77 iagnose febrile children using malaria rapid diagnostic tests, and treat positive malaria cases with

78 intervention, complementing improvements in diagnostic testing, antibiotic stewardship, and drug pip

79 Current diagnostic tests applied to inflammatory arthritis lack

80 cancer diagnosis and treatment is not ideal; diagnostic tests are accurate but invasive, and treatmen

81 Insofar as diagnostic tests are available or become available in th

82 Although immuno-based diagnostic tests are available, they have low sensitivit

83 Commercially available rapid diagnostic tests are based upon detection of the influen

84 dividual is infected can be challenging when diagnostic tests are imperfect and when some individuals

85 Current diagnostic tests are ineffective for identifying the eti

86 Because bacterial diagnostic tests are not accurate, antibiotics are frequ

87 use, and inexpensive point of care molecular diagnostic tests are urgently needed for the analysis of

88 ildhood Illness recommendations to use rapid diagnostic tests, artemisinin-based combination therapy,

89 Affordable, rapid point-of-care diagnostic tests (as have been developed for cryptococco

90 gle subject's sample(s) to evaluate multiple diagnostic tests at the same time, providing efficiencie

91 udy suggests the possible development of new diagnostic tests based on MOCOS expression, and paves th

92 Rapid diagnostic tests based on Plasmodium falciparum histidin

93 h care professionals to perform confirmatory diagnostic testing before initiating systemic therapy.

94 Lack of vaccines and reliable diagnostic tests, broad geographical distribution of mos

95 r NODAT, fructosamine may be a more accurate diagnostic test but this needs to be further examined in

96 Blood culture is the gold-standard diagnostic test, but is expensive, slow, and may under-d

97 actitioners in Occupational Health and rapid diagnostic testing by real-time polymerase chain reactio

98 ood and Drug Administration clearance of new diagnostic tests by promoting research that might not ha

99 These results showed that this diagnostic test can be used at the point of care for rap

100 further refinements before symptom-triggered diagnostic testing can be implemented.

101 However, the cost of implementing new rapid diagnostic testing can be significant, and such testing

102 nclusion of a healthy reference in biomarker diagnostic testing can potentially improve accuracy of d

103 viral testing results include somewhat poor diagnostic test characteristics for some tests, uncertai

104 PV) of FDG-PET/CT scans and other supporting diagnostic test characteristics, including time dependen

105 Campylobacter disease and the generally poor diagnostic test characteristics, this study calls into q

106 In this letter, culture-independent diagnostic tests (CIDTs) for detection of enteric pathog

107 The use of culture-independent diagnostic tests (CIDTs), such as stool antigen tests, a

108 nts with clinical malaria confirmed by rapid diagnostic test could be located to intervention or cont

109 A noninvasive diagnostic test could improve early diagnosis of sCJD an

110 Assuming diagnostic test data from a cross-sectional sample of in

111 a framework for the integration of multiple diagnostic test data with other information.

112 However, the usefulness of sequence-based diagnostic tests depends on the prevalence and dynamics

113 H. pylori remains the most commonly ordered diagnostic test despite recent expert recommendations.

114 underscored to highlight the need for novel diagnostic test development.

115 s potential targets to evaluate for improved diagnostic tests, effects on host cell biology that cont

116 pregnancy, but routine microscopic and rapid diagnostic tests fail to detect the vast majority of epi

117 Early PCR diagnostic tests focused on the MPa adhesion gene and th

118 an endogenous TTR ligand, could be used as a diagnostic test for ATTR V122I amyloidosis.

119 tional microscopy and culture as the initial diagnostic test for cerebrospinal fluid (CSF) if the sam

120 Despite the obstacles, a diagnostic test for hidden hearing loss is a worthwhile

121 human and financial terms, there is no clear diagnostic test for IC, but rather it is a disease of ex

122 port the future development of a urine-based diagnostic test for LUTS.

123 paration system was applied to a paper-based diagnostic test for malaria that produced an amplified c

124 5 pediatric inpatient admissions for which a diagnostic test for malaria was performed.

125 acid biosensor to develop a rapid molecular diagnostic test for MDR-TB.

126 , as well as clinical validation of BAT as a diagnostic test for multiple target allergens and confir

127 NAs have potential to develop a non-invasive diagnostic test for ovarian cancer.

128 Immunofluorescence is a highly specific diagnostic test for PCD, and it improves the speed and a

129 a fully automated sample-to-result molecular diagnostic test for rapid detection of Zaire ebolavirus

130 mmends the use of Xpert Ultra as the initial diagnostic test for suspected tuberculous meningitis.

131 Here we present a rapid diagnostic test for the accurate, quantitative assessmen

132 halitis (ME) Panel is a multiplexed in vitro diagnostic test for the simultaneous, rapid ( approximat

133 averted of introducing Xpert as the initial diagnostic test for tuberculosis, compared with sputum s

134 In 2010 a new diagnostic test for tuberculosis, Xpert MTB/RIF, receive

135 ied the development of a rapid point-of-care diagnostic test for Zika virus as a top research priorit

136 rpes simplex keratitis; 4 patients underwent diagnostic testing for Acanthamoeba keratitis.

137 clinical diagnosis with the limited role for diagnostic testing for children presenting with the typi

138 n reaction testing for Zika virus as well as diagnostic testing for Dengue fever and West Nile virus.

139 ransmitted, accentuate the need for accurate diagnostic testing for different applications new to the

140 ty, underscoring the potential role of rapid diagnostic testing for early identification of VRE.

141 nherited ciHHV-6A, underscoring the need for diagnostic testing for HHV-6 infection even in the prese

142 y-three evidence-based recommendations about diagnostic testing for latent tuberculosis infection, pu

143 Currently, diagnostic testing for Lyme disease is done by determina

144 ough WGS that had not been identified by NGS diagnostic testing for the 46 individuals with IRD.

145 This knowledge has enabled diagnostic testing for these diseases by enzyme-linked i

146 WHO recommends Xpert MTB/RIF as initial diagnostic testing for tuberculous meningitis.

147 dox-mediated transformations are included as diagnostic tests for catalytic activity.

148 ysis in which we evaluated the accuracy of 5 diagnostic tests for CPTB.

149 Current diagnostic tests for diffuse large B-cell lymphoma use t

150 Diagnostic tests for dry eye disease (DED), including oc

151 Ocular Surface Disease Index, together with diagnostic tests for dry eye syndrome, such as tear brea

152 resulted in accelerated development of rapid diagnostic tests for emergency outbreak preparedness.

153 Many diagnostic tests for GERD have been developed over the p

154 vides an overview of the currently available diagnostic tests for Lassa fever and their strengths and

155 o treat STIs and the limited availability of diagnostic tests for M. genitalium.

156 he evidence on the accuracy of screening and diagnostic tests for preeclampsia, the potential benefit

157 of evidence to guide clinicians in selecting diagnostic tests for recurrent or persistent wheezing.

158 sed as an enabling technology for simplified diagnostic tests for RNA viruses.

159 We assessed the accuracy of 3 different diagnostic tests for S. mansoni infection (stool microsc

160 New and improved diagnostic tests for sarcoidosis-associated uveitis are

161 s considered a target for the development of diagnostic tests for spotted fever.

162 Rapid and accurate molecular diagnostic tests for the most common causes of infectiou

163 Development of rapid diagnostic tests for tuberculosis is a global priority.

164 Current urinary diagnostic tests for urothelial cancer are expensive and

165 The current lack of accurate diagnostic testing hampers our ability to understand the

166 Purpose Molecular diagnostic testing has become an integral part of the ev

167 nsive availability of prenatal screening and diagnostic testing has led to increased detection of chr

168 sector, but a more dependable and responsive diagnostic testing has yet to be developed.

169 esponse (SVR), and the role of HCV infection diagnostic tests has had to evolve in order to meet chan

170 plementation of highly multiplexed molecular diagnostic tests have allowed clinical microbiology labo

171 Few robust biomarkers or diagnostic tests have been developed for hepatic steatos

172 Currently available diagnostic tests have variable accuracy, particularly in

173 ome performed in all patients (malaria rapid diagnostic test, hemoglobin, oximeter) and others in sel

174 is one of the most widely used point-of-care diagnostic tests; however, LFAs generally suffer from lo

175 Routine clinical diagnostic testing identified an intragenic de novo dele

176 Historically, large-scale diagnostic test implementation has been slow and incompl

177 vidual having a positive result of a malaria diagnostic test in the postflood period in villages bord

178 cleic acid testing (NAT) to routine clinical diagnostic testing in detection of known or novel viruse

179 used in clinical medicine to inform further diagnostic testing in individuals with suspected disease

180 ons for future therapeutic interventions and diagnostic testing in patients with this acute optic neu

181 Also discussed is the future direction of diagnostic testing in the context of further advances in

182 Gram stains remain the cornerstone of diagnostic testing in the microbiology laboratory for th

183 le productivity and investigating the use of diagnostic tests in a quantitative manner.

184 The most notable new diagnostic tests in DED are tear film osmolarity, inflam

185 We analyze the value of GERD diagnostic tests in evaluation of these troublesome, non

186 iplexing) is one of the key requirements for diagnostic tests in order to enable fast, accurate and d

187 reening tools during immunosuppression or as diagnostic tests in patients presenting with symptoms su

188 nology could provide sensitive onsite cancer diagnostic tests in resource-limited settings with the n

189 Available diagnostic tests include culture-dependent for bacterial

190 Additional diagnostic tests included those for eosinophils in the p

191 electing patients for appropriate downstream diagnostic testing including comprehensive echocardiogra

192 Additional diagnostic testing, including genetic testing, contribut

193 he ultimate gold standard, the future of all diagnostic tests, including invasive fractional flow res

194 nderscores the potential importance of rapid diagnostic tests, including sequence-based tests, to gui

195 ve tests must take in account the consequent diagnostic testing, invasive procedures, clinical outcom

196 This work addresses the design of an Ebola diagnostic test involving a simple, rapid, specific and

197 eactive and highly sensitive influenza rapid diagnostic tests (IRDTs) are required.

198 me time, inexpensive and minimally invasive, diagnostic test is urgently required, not only to confir

199 Diagnostic testing is central to determining the underly

200 ore, a high index of suspicion combined with diagnostic testing is essential component of severe acut

201 alysis when clinical judgment indicates that diagnostic testing is necessary in patients with possibl

202 Diagnostic testing is not harmonized, with marked variab

203 Diagnostic testing is recommended in women with "ovarian

204 emia by blood culture and nucleic acid-based diagnostic tests is insufficiently sensitive.

205 FQ molecular-based diagnostic tests may better predict treatment response t

206 ves an overview on the role of HCV infection diagnostic testing (molecular and serological tools) use

207 Previous reports on molecular rapid diagnostic testing (mRDT) do not consistently demonstrat

208 >1 in 4 patients have no record of glaucoma diagnostic testing of any type.

209 Diagnostic testing often assesses the cardiovascular or

210 xclude HSV-infected persons from a necessary diagnostic test or, alternatively, reduce the costs asso

211 ot confirmed by PCR, light microscopy, rapid diagnostic test, or histology.

212 Diagnostic test performance of normalized neuromelanin v

213 Point-of-care (POC) diagnostic testing platforms are a growing sector of the

214 Studies evaluating rapid diagnostic testing plus stewardship intervention have co

215 (95% confidence interval = 74-102%) of rapid diagnostic test-positive infections.

216 f HAI metrics may produce pressure to change diagnostic testing practices.

217 The molecular diagnostic test produces visual signals corresponding to

218 ent class modeling techniques for estimating diagnostic test properties of conventional culture techn

219 idence of malaria cases confirmed by a rapid diagnostic test (RDT) and a reduction of 69% (95% CI 65%

220 Antenatal malaria screening with a rapid diagnostic test (RDT) and treatment only of women with p

221 cases in Africa increasingly receive a rapid diagnostic test (RDT) before antimalarials are prescribe

222 nces of malaria infections missed by a rapid diagnostic test (RDT) for malaria are a concern.

223 pan-lactate dehydrogenase [HRP2/pLDH]) rapid diagnostic test (RDT) to differentiate uncomplicated fro

224 Rapid diagnostic test (RDT), microscopy, and polymerase chain

225 Poor specificity may negatively impact rapid diagnostic test (RDT)-based diagnostic strategies for ma

226 mbination therapies (ACTs) to positive rapid diagnostic test (RDT)-confirmed cases in children in 3 m

227 agnosis would benefit from a sensitive rapid diagnostic test (RDT).

228 red malaria infection by microscopy or rapid diagnostic test (RDT).

229 cted with P. falciparum as detected by rapid diagnostic testing (RDT) who were treated with antimalar

230 ardship program (ASP) intervention and rapid diagnostic testing (RDT).

231 ite infection status (as assessed by a rapid diagnostic test [RDT]), which is available in recent hou

232 Rapid diagnostic tests (RDTs) account for more than two-thirds

233 P. falciparum rapid diagnostic tests (RDTs) and molecular (polymerase chain

234 ed intermittent screening with malaria rapid diagnostic tests (RDTs) and treatment of RDT-positive wo

235 Rapid diagnostic tests (RDTs) are an important tool for malari

236 Multi-antigen rapid diagnostic tests (RDTs) are highly informative, simple,

237 Malaria rapid diagnostic tests (RDTs) are recommended at community poi

238 Commercial malaria rapid diagnostic tests (RDTs) detect P. falciparum histidine r

239 n Nigeria and evaluated the use of two rapid diagnostic tests (RDTs) for HIV.

240 While rapid diagnostic tests (RDTs) for the detection of IgG/IgM aga

241 Rapid diagnostic tests (RDTs) have transformed malaria diagnos

242 pecific histidine-rich protein 2-based rapid diagnostic tests (RDTs) to evaluate suspected malaria in

243 rventions that included use of malaria rapid diagnostic tests (RDTs), ACTs, and rectal artesunate whe

244 27, 2014, who were tested with malaria rapid diagnostic tests (RDTs), and administered questionnaires

245 t motivates exploration of noninvasive rapid diagnostic tests (RDTs).

246 rapid histidine-rich protein 2 (HRP2)-based diagnostic tests (RDTs).

247 the performance of HRP2-based malaria rapid diagnostic tests (RDTs).

248 Rapid diagnostic testing reduces the turnaround time for patho

249 e been detected, reducing the need for other diagnostic tests, reducing unnecessary use of antibiotic

250 Site-based diagnostic test reports were classified as normal or mil

251 llary testing from the plethora of available diagnostic tests requires preoperative communication bet

252 in reaction (RT-PCR) kit and a malaria rapid diagnostic test, respectively.

253 toms of C difficile infection and a positive diagnostic test result were recruited from 33 centres in

254 Here we show the effect of this procedure on diagnostic test results and infectious Ebola virus (EBOV

255 ropriate clinical action to translate faster diagnostic test results in the laboratory into improved

256 , capture history and current and historical diagnostic test results on the probability of being trul

257 ts based on clinical symptoms and additional diagnostic test results.

258 ing truly infected, given any combination of diagnostic test results.

259 pare accuracy of traditional rapid influenza diagnostic tests (RIDTs), digital immunoassays (DIAs), a

260 ecause of its non-specific symptoms, and the diagnostic tests routinely available do not offer the de

261 Diagnostic test sensitivity and specificity are probabil

262 ss-sectional study of de-identified residual diagnostic test serum samples from males aged 15-39 year

263 Accurate and reliable ZIKV diagnostic tests serve as an important tool for limiting

264 mography angiography (CTA) versus functional diagnostic testing strategies did not improve clinical o

265 mputed tomography angiography and functional diagnostic testing strategies in patients with suspected

266 nd the need for abundant products to develop diagnostic tests, synthesis of these compounds was consi

267 e Cepheid Xpert Carba-R assay, a qualitative diagnostic test that was designed for the rapid detectio

268 We also review the parameters present in diagnostic testing that allow for prognostic insight and

269 There are many diagnostic tests that are employed in the serological di

270 erefore vital to develop and deploy accurate diagnostic tests that can determine whether asymptomatic

271 iotic use requires the development of simple diagnostic tests that provide caregivers with reliable,

272 n how commercial AST systems can be used for diagnostic testing, the absence of up-to-date performanc

273 tion in attribution of adverse events during diagnostic testing, the current status of the ECA Black

274 When used in conjunction with malaria diagnostic tests, they may improve diagnostic specificit

275 ty of DNA methylation as a clinically useful diagnostic test to detect current heavy alcohol consumpt

276 The ability of a diagnostic test to detect multiple pathogens simultaneou

277 A rapid and reliable diagnostic test to distinguish ischemic from hemorrhagic

278 roblem is that there is no sufficiently fast diagnostic test to guide correct antibiotic prescription

279 mical analysis has been used as a predictive diagnostic test to identify responders and guide treatme

280 mical analysis has been used as a predictive diagnostic test to identify responders and guide treatme

281 We applied the developed diagnostic test to predict the tumour type of 216 well-c

282 as been proposed as an alternative serologic diagnostic test to the indirect immunofluorescence assay

283 ces of allergies among tree-nuts and improve diagnostic testing to minimize the need for OFC.

284 Study in Montreal, Quebec, Canada, provides diagnostic testing to women aged 50 years or older with

285 nary approach and relies on a combination of diagnostic tests to ascertain the work relatedness of th

286 Patients were administered the following diagnostic tests to correlate with fluorophotometry: OSD

287 The diagnostic tests to identify small fibre neuropathy incl

288 e, we review established and investigational diagnostic tests utilized for urogenital schistosomiasis

289 ion was often not performed but at least one diagnostic test was prescribed to most patients.

290 s the cause of AFI outbreaks where reference diagnostic testing was limited or unavailable.

291 of studies that evaluated the accuracy of a diagnostic test were sufficiently informative.

292 ccal nasopharyngeal cultures from whom viral diagnostic tests were obtained were enrolled.

293 During the study period, 7596 diagnostic tests were performed, and 1285 patients were

294 cimen types were collected, and a variety of diagnostic tests were performed.

295 Diagnostic tests were prescribed to 80.0%.

296 ar amenable to development of sequence-based diagnostic tests, whereas the undefined mechanisms of re

297 as focused intensely on development of rapid diagnostic tests, which (when coupled with educational a

298 o laboratories, and the use of point-of-care diagnostic tests, will also be important for ensuring ac

299 (n = 66), fructosamine was the most accurate diagnostic test with adjusted AUC of 0.93 (95% CI, 0.84-

300 CR on a subset of subjects who had undergone diagnostic testing with a multiple-antigen (histidine-ri